John Johnston
Family Medicine · Webster, TXNPI 1477547651
Payments from drug & device makers
Across 108 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$388
- AbbVie$326
- Antares Pharma, Inc.$242
- Amgen$97
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$87
- Eisai Inc.$85
- plus $804 from 24 others
What the payments were for
- Food & beverage$2,029100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $388 |
| AbbVie | 17 | $326 |
| Antares Pharma, Inc. | 11 | $242 |
| Amgen | 5 | $97 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $87 |
| Eisai Inc. | 4 | $85 |
| GSK | 3 | $69 |
| Tolmar, Inc. | 4 | $67 |
| Lilly USA, LLC | 4 | $67 |
| Pfizer | 3 | $56 |
| Verity Pharmaceuticals Inc. | 2 | $52 |
| Acella Pharmaceuticals, LLC | 3 | $50 |
| Acerus Pharmaceuticals Corporation | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Halozyme Inc | 2 | $37 |
| Optinose US, Inc. | 2 | $34 |
| Medtronic | 1 | $34 |
| Merck | 2 | $30 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Johnson & Johnson | 2 | $26 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Melinta Therapeutics, LLC | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Exact Sciences | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $13 |
| IBSA Pharma Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$2,029 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 31 | $29,533 |
| FarxigaDapagliflozin Propanediol | 12 | $21,762 |
| XareltoRivaroxaban | 17 | $12,680 |
| Np ThyroidThyroid,pork | 18 | $1,614 |
| Liothyronine Sodium | 30 | $1,463 |
| ValacyclovirValacyclovir Hcl | 19 | $1,452 |
| Temazepam | 13 | $1,217 |
| Testosterone Cypionate | 14 | $1,129 |
| Hydrocortisone | 22 | $1,126 |
| Calcitonin-SalmonCalcitonin,salmon,synthetic | 19 | $1,061 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 51 | $926 |
| Metoprolol Succinate | 31 | $848 |
| Levothyroxine Sodium | 43 | $708 |
| Gabapentin | 44 | $663 |
| Hydroxychloroquine Sulfate | 31 | $624 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $67 | $29,53331 claims |
| AstraZenecaFarxiga | $388 | $21,76212 claims |
| Johnson & JohnsonXarelto | $26 | $12,68017 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $50 | $1,61418 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $70843 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Webster
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.